抗血管內皮生長因子藥物治療牽牛花綜合征合并黃斑新生血管1例_Chinese Journal of Ocular Fundus Diseases

Authors：

陳智萍 ,  游志鵬 , 毛子清 , 吳泠瑤 , 談赟玉 , 蘇曉涵 , 田西鳳

南昌大學附屬眼科醫院, 南昌 330006;

Corresponding?author：

游志鵬, Email: yzp@sina.com

Keywords：

牽牛花綜合征; 先天性視盤發育異常; 黃斑新生血管; 病例報告

DOI：

10.3760/cma.j.cn511434-20221019-00553

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： 陳智萍, 游志鵬, 毛子清, 吳泠瑤, 談赟玉, 蘇曉涵, 田西鳳. 抗血管內皮生長因子藥物治療牽牛花綜合征合并黃斑新生血管1例. Chinese Journal of Ocular Fundus Diseases, 2024, 40(2): 148-149. doi: 10.3760/cma.j.cn511434-20221019-00553 Copy

1.	佘凱芩, 張琦, 趙培泉. 牽牛花綜合征診斷治療與遺傳和發病機制的研究現狀及進展[J]. 中華眼底病雜志, 2017, 33(5): 557-560. DOI: 10.3760/cma.j.issn.1005-1015.2017.05.034.She KQ, Zhang Q, Zhao PQ. The status and progress of morning glory syndrome[J]. Chin J Ocul Fundus Dis, 2017, 33(5): 557-560. DOI: 10.3760/cma.j.issn.1005-1015.2017.05.034.
2.	楊依柳, 楊婷婷, 陸方, 等. 新生血管性老年性黃斑變性亞型報告的國際新命名專家共識解讀[J]. 中華眼底病雜志, 2022, 38(2): 99-107. DOI: 10.3760/cma.j.cn511434-20220128-00055.Yang YL, Yang TT, Lu F, et al. Brief interpretation of the consensus nomenclature for reporting neovascular age-related macular degeneration data[J]. Chin J Ocul Fundus Dis, 2022, 38(2): 99-107. DOI: 10.3760/cma.j.cn511434-20220128-00055.
3.	Dempster AG, Lee WR, Forrester JV, et al. The 'morning glory syndrome'-a mesodermal defect?[J]. Ophthalmologica, 1983, 187(4): 222-230. DOI: 10.1159/000309330.
4.	吳素蘭, 毛劍波, 沈麗君. 玻璃體腔注射雷珠單抗治療兒童牽牛花綜合征合并脈絡膜新生血管一例[J]. 中華眼底病雜志, 2020, 36(8): 645-647. DOI: 10.3760/cma.j.cn511434-20190409-00130.Wu SL, Mao JB, Shen LJ. A case of intravitreal injection of leizumab in the treatment of morning glory syndrome complicated with choroidal neovascularization in children[J]. Chin J Ocul Fundus Dis, 2020, 36(8): 645-647. DOI: 10.3760/cma.j.cn511434-20190409-00130.
5.	Zou YH, She KQ, Ren JN, et al. Prophylactic juxtapapillary laser photocoagulation in pediatric morning glory syndrome[J]. Int J Ophthalmol, 2022, 15(5): 766-772. DOI: 10.18240/ijo.2022.05.12.

1. 佘凱芩, 張琦, 趙培泉. 牽牛花綜合征診斷治療與遺傳和發病機制的研究現狀及進展[J]. 中華眼底病雜志, 2017, 33(5): 557-560. DOI: 10.3760/cma.j.issn.1005-1015.2017.05.034.She KQ, Zhang Q, Zhao PQ. The status and progress of morning glory syndrome[J]. Chin J Ocul Fundus Dis, 2017, 33(5): 557-560. DOI: 10.3760/cma.j.issn.1005-1015.2017.05.034.
2. 楊依柳, 楊婷婷, 陸方, 等. 新生血管性老年性黃斑變性亞型報告的國際新命名專家共識解讀[J]. 中華眼底病雜志, 2022, 38(2): 99-107. DOI: 10.3760/cma.j.cn511434-20220128-00055.Yang YL, Yang TT, Lu F, et al. Brief interpretation of the consensus nomenclature for reporting neovascular age-related macular degeneration data[J]. Chin J Ocul Fundus Dis, 2022, 38(2): 99-107. DOI: 10.3760/cma.j.cn511434-20220128-00055.
3. Dempster AG, Lee WR, Forrester JV, et al. The 'morning glory syndrome'-a mesodermal defect?[J]. Ophthalmologica, 1983, 187(4): 222-230. DOI: 10.1159/000309330.
4. 吳素蘭, 毛劍波, 沈麗君. 玻璃體腔注射雷珠單抗治療兒童牽牛花綜合征合并脈絡膜新生血管一例[J]. 中華眼底病雜志, 2020, 36(8): 645-647. DOI: 10.3760/cma.j.cn511434-20190409-00130.Wu SL, Mao JB, Shen LJ. A case of intravitreal injection of leizumab in the treatment of morning glory syndrome complicated with choroidal neovascularization in children[J]. Chin J Ocul Fundus Dis, 2020, 36(8): 645-647. DOI: 10.3760/cma.j.cn511434-20190409-00130.
5. Zou YH, She KQ, Ren JN, et al. Prophylactic juxtapapillary laser photocoagulation in pediatric morning glory syndrome[J]. Int J Ophthalmol, 2022, 15(5): 766-772. DOI: 10.18240/ijo.2022.05.12.

Previous Article
Elevated blood pressure increases risk of proliferative diabetic retinopathy: a Mendelian randomization study
Next Article
急性滲出性多形性卵黃樣黃斑病變1例

Chinese Journal of Ocular Fundus Diseases

抗血管內皮生長因子藥物治療牽牛花綜合征合并黃斑新生血管1例

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content